PCSK9 is an enzyme that binds to and targets the LDL receptor for degradation, and a genetic association study found that a loss-of-function mutation of the PCSK9 gene was linked to lower levels of LDL cholesterol, lipoprotein(a) and a reduced incidence of AS 77. The gene discussed is PCSK9; the disease is aortic stenosis.